Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN7 | P35236 | 2/20 | 0.59 |
| ▸ | PPARD | Q03181 | 2/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.49 |
| ▸ | THRA | P10827 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL175681 | 0.90 | PPARD (0.50) | PTPN7PPARDALOX15TSHRHSD17B10 | |
| SCHEMBL15387243 | 0.87 | HSD17B10 (0.49) | PTPN7PPARDALOX15TSHRHSD17B10 | |
| SCHEMBL5383501 | 0.83 | PTPN7 (0.54) | PTPN7PPARDALOX15TSHRHSD17B10 | |
| SCHEMBL14640957 | 0.83 | MCL1 (0.63) | PTPN7PPARDALOX15TSHRHSD17B10 | |
| SCHEMBL22396697 | 0.83 | MCL1 (0.68) | PTPN7PPARDALOX15TSHRHSD17B10 | |
| SCHEMBL15721416 | 0.83 | PPARD (0.66) | PTPN7PPARDALOX15TSHRHSD17B10 | |
| SCHEMBL3301562 | 0.83 | PPARD (0.66) | PTPN7PPARDALOX15TSHRHSD17B10 | |
| SCHEMBL14435940 | 0.83 | MCL1 (0.68) | PTPN7PPARDALOX15TSHRHSD17B10 | |
| SCHEMBL11212981 | 0.82 | PDK2 (0.45) | HSD17B10LMNAALDH1A1MAPTMEN1 | |
| SCHEMBL17775077 | 0.82 | KDM4E (0.49) | PPARDHSD17B10ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3224266-B1 | METAL COMPLEXES OF SUBSTITUTED CATECHOLATES AND REDOX FLOW BATTERIES CONTAINING THE SAME | LOCKHEED MARTIN ENERGY LLC (US) | 2021-03-03 | — | — | EP | disclosed |
| EP-3271959-B1 | PREPARATION OF TITANIUM CATECHOLATE COMPLEXES IN AQUEOUS SOLUTION USING TITANIUM TETRACHLORIDE OR TITANIUM OXYCHOLORIDE | LOCKHEED MARTIN ENERGY LLC (US) | 2020-03-04 | — | — | EP | disclosed |
| US-10253051-B2 | Preparation of titanium catecholate complexes in aqueous solution using titanium tetrachloride or titanium oxychloride | LOCKHEED MARTIN ENERGY, LLC (US) | 2019-04-09 | — | — | US | disclosed |
| US-9837679-B2 | Metal complexes of substituted catecholates and redox flow batteries containing the same | LOCKHEED MARTIN ADVANCED ENERGY STORAGE, LLC (US) | 2017-12-05 | — | — | US | disclosed |
| WO-2016149336-A1 | PREPARATION OF TITANIUM CATECHOLATE COMPLEXES IN AQUEOUS SOLUTION USING TITANIUM TETRACHLORIDE OR TITANIUM OXYCHOLORIDE | LOCKHEED MARTIN ADVANCED ENERGY STORAGE, LLC (US) | 2016-09-22 | — | — | WO | disclosed |
| US-20160272659-A1 | PREPARATION OF TITANIUM CATECHOLATE COMPLEXES IN AQUEOUS SOLUTION USING TITANIUM TETRACHLORIDE OR TITANIUM OXYCHLORIDE | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2016-09-22 | — | — | US | disclosed |
| WO-2016086163-A1 | METAL COMPLEXES OF SUBSTITUTED CATECHOLATES AND REDOX FLOW BATTERIES CONTAINING THE SAME | LOCKHEED MARTIN ADVANCED ENERGY STORAGE, LLC (US) | 2016-06-02 | — | — | WO | disclosed |
| US-20160149251-A1 | METAL COMPLEXES OF SUBSTITUTED CATECHOLATES AND REDOX FLOW BATTERIES CONTAINING THE SAME | LOCKHEED MARTIN ENERGY, LLC | 2016-05-26 | — | — | US | disclosed |
| WO-2009017848-A9 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES SUCH AS SYSTEMIC AA AMYLOIDOSIS | PROTEO TECH INC (US) | 2009-04-30 | — | — | WO | disclosed |
| WO-2009017848-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES SUCH AS SYSTEMIC AA AMYLOIDOSIS | PROTEO TECH INC. (US) | 2009-02-05 | — | — | WO | disclosed |
| WO-2008097692-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASES | PROTEOTECH INC. (US) | 2008-08-14 | — | — | WO | disclosed |
| EP-1511710-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER S DISEASE, TYPE 2 DIABETES, AND PARKINSON S DISEASE | Proteotech, Inc. (US) | 2005-03-09 | — | — | EP | disclosed |
| WO-2003101927-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE | PROTEOTECH, INC. (US) | 2003-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160149251-A1 | METAL COMPLEXES OF SUBSTITUTED CATECHOLATES AND REDOX FLOW BATTERIES CONTAINING THE SAME | COMT, SLC39A14, SOD1 | PTPN7 1362/4885PPARD 3890/4885ALOX15 2640/4885 |
| US-10253051-B2 | Preparation of titanium catecholate complexes in aqueous solution using titanium tetrachloride or titanium oxychloride | COMT, TYR, TH | PTPN7 756/4885PPARD 4084/4885ALOX15 3243/4885 |
| US-20160272659-A1 | PREPARATION OF TITANIUM CATECHOLATE COMPLEXES IN AQUEOUS SOLUTION USING TITANIUM TETRACHLORIDE OR TITANIUM OXYCHLORIDE | COMT, TYR, TH | PTPN7 756/4885PPARD 4084/4885ALOX15 3243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.